-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Delays in diabetic foot screening and timely treatment of acute foot complications may have contributed to the increase in amputations during the COVID-19 pandemic
Delays in diabetic foot screening and timely treatment of acute foot complications during the COVID-19 pandemic may have contributed to the increase in amputations
DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study included all adult residents of Ontario, Canada with diabetes, and compared January 1, 2020 to February 23, 2021 with January 1, 2019 to Ratio of selected outcomes during February 23, 2020
Main outcomes and measures: Comprehensive assessment of diabetes care including foot examination, glycated hemoglobin (HbA1c) measurement, diabetic foot ulcer, osteomyelitis, emergency department visits or hospitalizations for gangrene, lower extremity patency or endovascular revascularization, minor (toe or partial) Foot) amputation, major (above the ankle) amputation
Results: On March 11, 2020, the study included 1488 605 adults with diabetes (median [IQR] age, 65 [55-74] years; 776 665 [52.
Table 1 Demographic characteristics and complications of amputees by period
Table 1 Demographic characteristics and complications of amputees by periodFigure 1 Amputation rate among adults with diabetes
Figure 1 Amputation rate among adults with diabetesTable 2 Prognosis and nursing measures of adults with diabetes by time period
Table 2 Prognosis and nursing measures of adults with diabetes by time periodFigure 2 Prognosis and care measures ratios in the 2020-2021 period relative to the 2019-2020 control period
Figure 2 Prognosis and care measures ratios in the 2020-2021 period relative to the 2019-2020 control periodConclusions: In this population-based cohort study, COVID-19 pandemic-related interruptions in care were not associated with excessive leg amputations among diabetic patients
In this population-based cohort study, COVID-19 pandemic-related interruptions in care were not associated with excessive leg amputations among people with diabetes
de Mestral C, Gomez D, Wilton AS, et al.
A Population-Based Analysis of Diabetes-Related Care Measures, Foot Complications, and Amputation During the COVID-19 Pandemic in Ontario, Canada JAMA
Leave a Comment